Contraception Clinical Trial
— Mobile WACh XYOfficial title:
Evaluation of an mHealth SMS Dialogue Strategy to Meet Women's and Couples' Postpartum Contraceptive Needs in Kenya
NCT number | NCT02781714 |
Other study ID # | 51125 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | July 2016 |
Est. completion date | September 2017 |
Verified date | April 2018 |
Source | University of Washington |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Meeting women's need for postpartum family planning is has been acknowledged as a global
priority in maternal and child health. The prevention of unintended pregnancies in
sub-Saharan African countries, which carry the highest global burdens of maternal mortality
and HIV infection, is projected to substantially decrease maternal and neonatal morbidity and
mortality. Many barriers to contraceptive uptake exist, both within and outside of the
postpartum time period, and include socio-cultural, economic, and supply-side factors.
Furthermore, while the importance of engaging men in family planning programs has been
acknowledged for decades, few interventions have succeeded in increasing male involvement in
family planning while maintaining a focus on women's empowerment. Innovative approaches to
meeting the family planning needs of women and couples are urgently needed.
Public health interventions are increasingly incorporating mobile health (mHealth) approaches
using short message service (SMS) technology in low-income countries, approaches that have
demonstrated benefit among various reproductive health outcomes. The investigators
hypothesize that personalized, bidirectional SMS dialogue with individual women and couples
will increase postpartum contraceptive uptake, thereby decreasing unmet need for family
planning in Kenya. The investigators have collaborated with the University of Washington (UW)
Department of Computer Science and Engineering (CSE) along with Kenyan telecommunication
providers to develop a hybrid messaging system that allows for innovative bidirectional SMS
messaging. This system has been used successfully in maternal child health (MCH) clinics in
Kenya. In qualitative research, women in Kenya have expressed a strong desire for mHealth
support to provide additional education, counseling and reminders to supplement counseling by
health workers.
The investigators propose a randomized controlled trial (RCT) comparing the effects of
bidirectional SMS dialogue vs. control on highly effective contraceptive use at 6 months
postpartum among HIV negative women and couples in Nyanza Province, Kenya. Data from this RCT
and accompanying qualitative study will contribute to innovative, scale-able strategies to
address unmet need for contraception and increase male involvement in family planning.
Status | Completed |
Enrollment | 260 |
Est. completion date | September 2017 |
Est. primary completion date | September 2017 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 14 Years to 50 Years |
Eligibility |
Inclusion Criteria: - Pregnant; at least 28 weeks gestation - HIV negative - Daily access to a mobile phone - Planning to stay in area for 6 months postpartum - Able to read/write or has trusted person to help Exclusion Criteria: - Does not meet above criteria |
Country | Name | City | State |
---|---|---|---|
Kenya | Ahero sub-County Hospital | Ahero | Kisumu County |
Kenya | Bondo County Hospital | Bondo | Siaya County |
Lead Sponsor | Collaborator |
---|---|
University of Washington | Kenyatta National Hospital, University of Nairobi |
Kenya,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Highly-effective contraceptive use | Proportion of participants self-reporting use of oral contraceptive pills, injectable contraception, contraceptive implant, intrauterine device, or male/female sterilization at 6 months postpartum will be compared between arms. Questionnaires will be used to assess this outcome. | 6 months postpartum | |
Secondary | Time to contraceptive use | Time postpartum at which contraceptive use was initiated | Through study completion (6 months postpartum) | |
Secondary | Dual contraceptive use | Percentage of sexual acts in which a condom was used among contraceptive users | 6 weeks, 14 weeks, and 6 months postpartum | |
Secondary | Any contraceptive use | Proportion of participants self-reporting use of any contraceptive method will be compared between arms. This outcome will be assessed with a questionnaire. | 6 weeks, 14 weeks, and 6 months postpartum | |
Secondary | Family planning satisfaction questionnaire | Satisfaction with chosen contraceptive method | 6 weeks, 14 weeks, and 6 months postpartum | |
Secondary | Exclusive breastfeeding questionnaire | Self-reported exclusive breastfeeding | 6 weeks, 14 weeks, and 6 months postpartum |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02577601 -
Impact of Combined Hormonal Contraceptives on UPA
|
Phase 4 | |
Completed |
NCT03153644 -
Improving Contraceptive Care for Women With Medical Conditions
|
||
Completed |
NCT04112095 -
Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use
|
Phase 3 | |
Recruiting |
NCT05521646 -
Implementing Best Practice Postpartum Contraceptive Services Through a Quality Improvement Initiative
|
N/A | |
Active, not recruiting |
NCT04291001 -
Ovarian Function With ENG Implant and UPA Use
|
Early Phase 1 | |
Completed |
NCT04568980 -
Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
|
||
Completed |
NCT03438682 -
Real World Effectiveness and Safety of Hysteroscopic (Essure®) Compared to Laparoscopic Sterilization
|
||
Active, not recruiting |
NCT01948882 -
Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women
|
N/A | |
Enrolling by invitation |
NCT04997499 -
Adolescent Subcutaneous (SQ) Injection Video Validation
|
N/A | |
Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 | |
Completed |
NCT04463680 -
Rifampin and the Contraceptive Implant
|
Phase 4 | |
Completed |
NCT03154125 -
Sayana® Press Extension Study
|
Phase 3 | |
Withdrawn |
NCT03725358 -
A Cluster-RCT to Increase the Uptake of LARCs Among Adolescent Females and Young Women in Cameroon.
|
N/A | |
Completed |
NCT02957630 -
"E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"
|
Phase 1/Phase 2 | |
Completed |
NCT02718222 -
Impact and Performance of Institutionalizing Immediate Post-partum IUD Services
|
N/A | |
Completed |
NCT02456584 -
Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods
|
Phase 1 | |
Recruiting |
NCT02121067 -
LNG-IUS at 2 Weeks Postpartum
|
Phase 4 | |
Terminated |
NCT02169869 -
Immediate Postplacental IUD Insertion
|
N/A | |
Recruiting |
NCT02292056 -
Medication Safety and Contraceptive Counseling for Reproductive Aged Women With Psychiatric Conditions
|
N/A | |
Withdrawn |
NCT01930994 -
Kenya Sino-implant (II) PK Study
|
N/A |